http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1803005_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340094485_AID1803005_PMID_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340094485_AID1803005_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340094485_AID1803005_PMID_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID340094485_AID1803005_PMID_VALUE2
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05177
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33261
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08684
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10635
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title Inhibitory Assay from US Patent US9353089: \"Compositions and methods for the treatment of malaria\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID340094485
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1803005

Total number of triples: 13.